Literature DB >> 8923712

In vitro measurements of inertial cavitation thresholds in human blood.

C X Deng1, Q Xu, R E Apfel, C K Holland.   

Abstract

Inertial cavitation thresholds were measured in human blood exposed to pulsed ultrasound. Freshly drawn blood, bank blood and aqueous dilutions of both were used in this experimental study. Micrometer-sized polystyrene particles were used as extra potential nuclei in some samples. Focused transducers with megahertz center frequencies (2.5 MHz, 4.3 MHz) were employed to generate pulsed ultrasound to induce cavitation. Specially designed cells for hosting the blood samples were made to adapt to the experimental environment. Cavitation threshold measurements were achieved by using an active cavitation detection scheme which utilizes a highly focused transducer with a much higher center frequency (30 MHz). In 50% diluted blood samples, when no polystyrene particles were added to the samples, the threshold for cavitation was about 4.1 MPa at 2.5 MHz, while no cavitation was detected at 4.3 MHz. Generally, the measured thresholds decrease in samples with lower volume concentration of red blood cells or when polystyrene particles were added to the samples. Results show that the measured thresholds in some circumstances are in the range of output pressure of diagnostic ultrasound instrumentation; but for whole, freshly drawn blood, our apparatus was unable to detect cavitation, even at 6.3 MPa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923712     DOI: 10.1016/0301-5629(96)00104-4

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  22 in total

Review 1.  Section 8--clinical relevance. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 2.  Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 3.  Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 4.  Section 4--bioeffects in tissues with gas bodies. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

5.  Correlation of cavitation with ultrasound enhancement of thrombolysis.

Authors:  Saurabh Datta; Constantin-C Coussios; Louis E McAdory; Jun Tan; Tyrone Porter; Gabrielle De Courten-Myers; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2006-08       Impact factor: 2.998

6.  Potentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optison™ & SonoVue(®)).

Authors:  Azita Soltani; Ruchi Singhal; Melissa Obtera; Ronald A Roy; Wayne M Clark; Douglas R Hansmann
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

7.  Targeted long-term venous occlusion using pulsed high-intensity focused ultrasound combined with a pro-inflammatory agent.

Authors:  Yufeng Zhou; Jasmine Zia; Cinderella Warren; Frank L Starr; Andrew A Brayman; Lawrence A Crum; Joo Ha Hwang
Journal:  Ultrasound Med Biol       Date:  2011-08-06       Impact factor: 2.998

8.  Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Authors:  Azita Soltani; Wayne M Clark; Douglas R Hansmann
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

9.  Probability of cavitation for single ultrasound pulses applied to tissues and tissue-mimicking materials.

Authors:  Adam D Maxwell; Charles A Cain; Timothy L Hall; J Brian Fowlkes; Zhen Xu
Journal:  Ultrasound Med Biol       Date:  2013-02-04       Impact factor: 2.998

Review 10.  Ultrasound-mediated drug delivery for cardiovascular disease.

Authors:  Jonathan T Sutton; Kevin J Haworth; Gail Pyne-Geithman; Christy K Holland
Journal:  Expert Opin Drug Deliv       Date:  2013-03-01       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.